Neoplasia/BPH

	Diagnostic value of PRIMARY score and a combined model with SUVmax in 18F-PSMA-1007 PET/CT for prostate cancer. Front Med (Lausanne) Hu F, Li X, Li Z, Huang W, Liu W, Lian S, Liu S. PMID: 42200055 [PubMed]
	Comparative evaluation of composite inflammatory indices for predicting prostate cancer risk and mortality: a NHANES-based study with external validation. Front Oncol Chen H, Lei J, Zhang W, Wang Z, Liu R, Chen L. PMID: 42200020 [PubMed]
	Trends in the diagnosis of variant bladder cancer: a national retrospective cohort analysis. Front Oncol Rahman SN, Keervani K, Zhao X, Perry CJ, Mu P, Martin D, Tan WS, Hesse DG, Petrylak DP, Warrick J, Kumar D, Humphrey PA, Ghali F. PMID: 42200013 [PubMed]
	Integrated bulk and single-cell transcriptomics reveals TREH as a novel protective biomarker and prognostic predictor in clear cell renal cell carcinoma. Front Oncol Ma K, Wang Y, Xue X, Hu J, Li L. PMID: 42200006 [PubMed]
	Emerging Therapeutic Strategies in Metastatic Hormone-Sensitive Prostate Cancer. J Immunother Precis Oncol Castro EA, Jani YC, Bilen MA. PMID: 42199608 [PubMed]
	Highly Vascularized Scars in Cases of Regressed Testicular Germ Cell Tumors: An Occasional Mimic of Hemangioma and a Diagnostic Pitfall. Am J Surg Pathol Ulbright TM, Toklu A, Acosta AM. PMID: 42199017 [PubMed - as supplied by publisher]
	On-Clamp Versus Off-Clamp Robot-Assisted Partial Nephrectomy for Localized Renal Tumors: A Retrospective Single-Center Cohort Study. Diagnostics (Basel) Stoeva-Grigorova S, Marinov S, Abushev P, Kirilov P, Nikolov D, Kalinov T, Kolev N, Zlatarov A, Stoev L, Dzhenkov D. PMID: 42196908 [PubMed]
	Prioritising Data Quality Governance for AI in Prostate Cancer: A Methodological Proof-of-Concept Study Using Neural Networks for Risk Stratification. Diagnostics (Basel) Talavera-Cobo V, Robles-Garcia JE, Guillen-Grima F, Calva-Lopez A, Tapia-Tapia M, Labairu-Huerta L, Ancizu-Marckert FJ, Guillen-Aguinaga L, Sanchez-Zalabardo D, Miñana-Lopez B. PMID: 42196820 [PubMed]
	A Review of Approaches to the Synthesis of DCL-Based Prostate-Specific Membrane Antigen Ligands. Int J Mol Sci Zyk NY, Butakova NS, Machulkin AE, Beloglazkina EK. PMID: 42196616 [PubMed - indexed for MEDLINE]
	Silybum marianum-Derived Compounds in Prostate Cancer: Mechanisms of Action and Translational Potential. Int J Mol Sci Randisi F, Modoni G, Riva M, Perletti G, Odorico D, Marras E, Gariboldi MB. PMID: 42196582 [PubMed - indexed for MEDLINE]
	Natural Products in Clear Cell Renal Cell Carcinoma: Rewiring the VHL-HIF Axis, Metabolic Plasticity, and Tumor-Immune Interactions. Int J Mol Sci Tsai YC, Tsai CC, Tsai VFS, Lin CH, Kuo CY. PMID: 42196561 [PubMed - indexed for MEDLINE]
	AKT2 Exon 3 Variants and Their Prevalence in Prostate Cancer Patients: Insights from a Jordanian Clinical Cohort. Int J Mol Sci Rahahlah N, Al-Alami Z, Alorjani MS, Al-Smadi A, Obeidat S, Otoom R, Al-Zoubi RM, Al Bashir S, Al Zoubi MS. PMID: 42196210 [PubMed - indexed for MEDLINE]
	Olfactory Science and Technology in Prostate Cancer Diagnosis: From Invertebrate Models to Artificial Intelligence. Life (Basel) Hegazi MAAA, Monari MN, Pasqualini F, Beltrame S, Martella C, Bax C, Tidu L, Capelli LM, Taverna G, Grizzi F. PMID: 42195404 [PubMed]
	Enhanced Imaging in Bladder Cancer: Fluorescence Cystoscopy and Molecular Diagnostics. Life (Basel) Godlewski D, Aebisher D, Bartusik-Aebisher D, Dynarowicz K, Smolak B, Krupka-Olek M, Kawczyk-Krupka A. PMID: 42195383 [PubMed]
	Systems Biology and Multi-Omics Determinants of Response to Bladder-Preserving Trimodality Therapy in Muscle-Invasive Bladder Cancer. Life (Basel) Schi, Munteanu VC, Borz MB, Cojocaru I, Morari O, Gîrbovan M, Ti. PMID: 42195381 [PubMed]
	Prognostic Value of the Prognostic Nutritional Index in Patients with Locally Advanced Bladder Cancer Receiving Perioperative Chemotherapy: A Multicenter Real-World Study. Medicina (Kaunas) Karakayal, Seyyar M, , , Karabu, Ate, Bacak B, Baykara M, Turhan G, Akar H, Ekinci F, Ery, Ye, Akba, Kalem A, Y, Demirdelen E, Ta, Y, Tanr, Sever N, Çabuk D, Kefeli U, Uygun K. PMID: 42195245 [PubMed - indexed for MEDLINE]
	5 Alpha Reductase Inhibitors (5ARIs) Monotherapy and Combinations: Current Role in Benign Prostatic Hyperplasia (BPH) Management. Medicina (Kaunas) Roidos C, Sountoulides P, Papathanasiou K, Symeonidis A, Mykoniatis I. PMID: 42195228 [PubMed - indexed for MEDLINE]
	Comparative Neurocognitive Outcomes Following Holmium Laser Enucleation and Transurethral Resection of the Prostate: A Prospective Cohort Study. Medicina (Kaunas) Özkaptan O, Çanakc, Dinçer E, , Do, Türky, Co, Özkaptan SD. PMID: 42195224 [PubMed - indexed for MEDLINE]
	Metastatic Patterns and Adverse Histopathologic Features in Advanced Renal Cell Carcinoma: A Five-Year Single-Center Retrospective Pathology Study. Medicina (Kaunas) Vidac A, Dema A, Barna R, Jurescu A, Natarâ, Hurmuz I, Nicolcea D, Dema V. PMID: 42195158 [PubMed - indexed for MEDLINE]
	DHT-Induced lncRNA AC092718.4 Promotes Prostate Cancer Cell Proliferation via ceRNA Mechanism. Genes (Basel) Jin L, Feng S, Sun WJ, Ouyang J, Liu F, Lu BC, Zhang YP, Zhao H. PMID: 42194995 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 188169

Page 1 of 9409



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy